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Polymers of Z α1-antitrypsin are secreted
in cell models of disease
To the Editor:
The α1-antitrypsin (α1-AT) is a 52 kDa glycoprotein that is predominantly synthesised in the liver and
secreted into the circulation, where it protects the lungs from the enzyme neutrophil elastase. α1-AT
deficiency (α1-ATD) is caused by mutations in the α1-AT gene, with most cases resulting from
homozygous inheritance of the Z allele (Glu342Lys). This leads to low levels of circulating α1-AT,
uncontrolled elastase activity and emphysema [1]. The Z mutation destabilises the native α1-AT and causes
the formation of aberrant polymers that accumulate within the endoplasmic reticulum (ER) of
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hepatocytes, giving rise to inclusion bodies that are the main histological feature of α1-ATD [2].
Extracellular polymers have been found in lung lavage, the skin of an individual with panniculitis and the
kidney of an individual with vasculitis [1], and are also present in the circulation of all individuals homo-
or heterozygous for the Z allele [3]. Circulating polymers originate in the liver, since they became
undetectable in the plasma of an individual 4 days after liver transplantation [3], but it is unknown
whether polymers can be secreted from hepatocytes or can form in the extracellular environment from
secreted monomeric Z α1-AT. Extracellular polymers are chemotactic and stimulatory for human
neutrophils [4] and may contribute to inflammatory neutrophil infiltration in the lungs, kidney and skin.
It is important to understand where these polymers form in order to design effective therapies for
emphysema and other pathological manifestations of α1-ATD. Here we investigated the origin of
extracellular polymers by exploiting our cellular models of α1-ATD and conformer-specific and functional
monoclonal antibodies (mAb) against Z α1-AT [5–8].
We first confirmed the presence of α1-AT polymers in the plasma of three PiZZ individuals by
non-denaturing PAGE and the polymer-specific mAb-2C1 [5] (figure 1a). Similarly, when expressed in
human embryonic kidney (HEK) 293 T-cells Z α1-AT was detected in the culture medium as a mix of
monomer and polymers (figure 1b). To exclude the possibility that polymers were released into the culture
medium from damaged cells, we analysed the glycosylation state of extracellular α1-AT. Secretory
glycoproteins are synthesised in the ER, modified in the Golgi apparatus where N-linked glycans increase
in size and complexity, and arrive to the trans-Golgi network (TGN) for sorting and secretion. We
ascertained the state of N-linked glycosylation by treating both M and Z α1-AT with endoglycosidase
H (endo H) that removes pre-Golgi glycans or peptide-N-glycosidase F (PNGase F) that removes all
N-linked glycans. Digestion with endo H showed that all extracellular α1-AT contained only mature, endo
H-resistant N-glycans, which were removed by PNGase F giving the expected size for non-glycosylated
α1-AT (figure 1c), demonstrating that extracellular polymers bare mature N-glycans, resulting from their
transport through the Golgi or from extracellular polymerisation of monomeric Z α1-AT, but not from
direct release of immature ER proteins.
We next used our polymerisation-blocking mAb-4B12 [8] to prevent Z α1-AT polymerisation in cell
culture medium. This antibody blocks polymer formation at a molar ratio of 1:1 for Z α1-AT and
mAb-4B12 in vitro, so adding it in excess to the culture medium should inhibit the polymerisation of
secreted monomeric Z α1-AT. Chinese hamster ovary (CHO) cells expressing Z α1-AT under a
Tet-inducible promoter [7] were cultured for 24 h with or without mAb-4B12 at a molar ratio of 1:1 or 1:2
for Z α1-AT and mAb-4B12). There was no difference in polymeric Z α1-AT in the culture media by
ELISA (figure 1d), indicating that polymers were secreted from the cells. The presence of a complex
between secreted Z α1-AT and mAb-4B12 was confirmed by ELISA, demonstrating binding of mAb-4B12
to secreted Z α1-AT (not shown). The secretory origin of extracellular polymers was further supported by
the observation that culture medium from CHO cells expressing Z-A1AT induced for 48 h and further
incubated in the absence of cells for 72 h showed no increase in polymer levels (not shown).
M α1-AT is readily secreted and can be detected by immunofluorescence within the Golgi compartment
[5, 7, 9–11]. Although polymers of Z and other mutant variants of α1-AT are found in the culture medium
of expressing cells, they have never been shown to co-localise with Golgi-resident proteins [5, 7, 10, 11].
This may be due to very low levels of these proteins transiting the Golgi at steady state, and so we used a
temperature block by culturing cells at 20°C, which reduces the exit of secretory proteins from the Golgi
apparatus without affecting ER to Golgi transport [12]. Secretion of M and Z α1-AT from transiently
transfected COS-7 cells was reduced 5- and 2-fold upon incubation at 20°C for 4 h (data not shown).
In these conditions, we assessed the co-localisation of 2C1-positive polymers with resident proteins of the
secretory pathway: BiP (ER), giantin (cis-medial-Golgi) and TGN-46 (TGN). The majority of 2C1-positive
Z α1-AT co-localised with BiP, confirming polymer accumulation within the ER [5, 7], but we also observed
partial co-localisation with giantin and TGN-46 (figure 1e), supporting their transiting through the Golgi
apparatus and exiting the cells via the canonical secretory pathway.
In order to confirm our results we used myc- and haemagglutinin epitope (HA)-tagged versions of M and
Z α1-AT (Mmyc, Zmyc, MHA and ZHA) to transiently transfect from HEK293 T-cells. We expressed each
version of Z α1-AT or different mixes of the M and Z α1-AT constructs, as described in figure 1f. We also
created a new experimental condition by collecting, mixing and replating cells transfected separately with
ZHA and Zmyc (figures 1f and g, lane 4). All the transfections were successful in producing similar
amounts of α1-AT (figure 1f top panel), monomeric for the M α1-AT and polymeric for the Z α1-AT
constructs (figure 1f, bottom panel). We then performed immunoprecipitation of the culture media with
anti-HA antibodies, followed by Western blot with an anti-myc-tag antibody and an anti-total α1-AT
antibody in the same membrane. All samples containing ZHA gave a positive signal with the anti- α1-AT
antibody, demonstrating an efficient immunoprecipitation (figure 1g, bottom panel), but only cells
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FIGURE 1 Extracellular polymers of Z α1-antitrypsin (α1-AT) do not form in the extracellular medium, but are secreted from cells via the Golgi complex.
a) Polymers of Z α1-AT were found in the plasma of three PiZZ α1-AT deficiency individuals but not in plasma from a control donor by non-denaturing
PAGE (stacking gel pH 6.8, separating gel pH 8.8) and Western blot analysis using the polymer-specific monoclonal antibodies (mAb) 2C1. b) The
culture medium of human embryonic kidney (HEK) 293 T-cells expressing M α1-AT contained only monomeric protein, while Z α1-AT was found as
monomeric and polymeric forms after non-denaturing PAGE and Western blot analysis for total α1-AT. The differences in band patterns and
background levels between the polymer ladders in a) and b) are probably due to high protein concentrations in plasma samples compared to
serum-free culture medium supernatants. c) Cell lysates (Lys) and culture media (Med) of cells in b) treated or not treated (-) with endoglycosidase H
(Endo H) or peptide-N-glycosidase F (PNGase F) and analysed by SDS PAGE and Western blot for total α1-AT. All extracellular α1-AT carried mature
N-glycosylation (55 kDa), while intracellular α1-AT showed immature N-glycosylation (
#) and deglycosylated α1-AT (
¶). d) Expression of Z α1-AT was
induced in Chinese hamster ovary stable cells with 0.5 µg·mL−1 doxycycline (Dox) and simultaneously incubated with purified mAb-4B12 at a molar
ratio of 1:1 or 1:2 for Z α1-AT and mAb-4B12 for 24 h; the amount of extracellular polymers as quantified by sandwich ELISA (2C1-Ag-9C5-HRP) did not
change in the presence of the polymerisation-blocking antibody. e) Immunodetection of Z α1-AT polymers with mAb-2C1 (red) in co-localisation with
resident proteins (green) of the endoreticulum (BiP), cis/medial Golgi (Giantin) and trans-Golgi network (TGN-46); the cell nucleus was counter-stained
with diaminophenylindole. Scale bars=10 µm and 5 µm in the main panel and close-up panel, respectively. All panels were obtained in a Zeiss
LSM510META confocal microscope (Zeiss, Jena, Germany) with a ×63 oil objective. f) HEK293 T-cells were transiently transfected with vectors encoding
ZHA (lane 1) or Zmyc (lane 2), or co-transfected with ZHA/Zmyc (lane 3), MHA/Mmyc (lane 5) or ZHA/Mmyc (lane 6); an additional condition was created by
detaching, mixing and replating equal numbers of ZHA and Zmyc cells (lane 4) at the end of the fifth transfection. After an overnight incubation in normal
culture medium, cells were further incubated for 24 h in serum-free medium, and culture media were analysed by SDS- or non-denaturing PAGE.
g) Culture media as in f) were immunoprecipitated with an anti-haemagglutinin (HA) antibody and analysed by SDS PAGE and immunoblot with an
anti-myc HRP mAb (top panel), then stripped and re-probed with the 2G7 anti-total α1-AT mAb (bottom panel). h) Plasma from four different ZZ patient
donors was incubated for the times indicated at 37°C and analysed by sandwich ELISA with the mAb-2C1. The graph shows the amount of Z α1-AT
polymers normalised to time 0.
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co-transfected with ZHA and Zmyc showed a band positive to the anti-myc antibody, demonstrating the
presence of ZHA/Zmyc heteropolymers in their culture medium (fig. 1g top panel). In contrast, cells
transfected separately with ZHA and Zmyc that were afterwards cultured together showed no signal with the
anti-myc antibody. These results support the intracellular origin of secreted polymers.
Taken together, our results indicate that polymers formed within the ER can traffic through this organelle
and be secreted via the Golgi compartment, where N-glycans acquire their mature configuration. Our
biochemical and immunofluorescence results do not exclude polymer formation in post-ER compartments.
The existing literature and our present data are in keeping with polymerisation occurring mostly within the
ER, where insoluble long-chain polymers are trapped within inclusion bodies, while at least part of the
soluble, short-chain polymers can enter transport vesicles for secretion. Our present observations suggest
that polymers secreted from hepatocytes can contribute to circulating polymers. Although the
concentration of monomeric Z α1-AT in plasma is probably high enough to allow extracellular
polymerisation, we did not observe an increase in polymer levels when plasma samples from PiZZ patients
were incubated at 37°C for 72 h (figure 1h). This can be due to limitations in our experimental conditions
or to the presence of polymerisation-inhibitory factors in plasma. Our results are also compatible with local,
extracellular polymer formation in the lung during inflammation and particularly by exposure to cigarette
smoke [13]. In conclusion, our present results show for the first time that polymers of Z α1-AT are secreted
from cells, supporting a contribution of intracellular origin to circulating polymers in α1-AT D.
@ERSpublications
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